Evidence map›Paper›PMID 36840632›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Stepwise Amplification of Circularly Polarized Luminescence in Chiral Metal Cluster Ensembles.

Jia-Yin Wang, Yubing Si, Xi-Ming Luo, Zhao-Yang Wang, Xi-Yan Dong, Peng Luo, Chong Zhang, Chunying Duan, Shuang-Quan Zang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Stepwise Amplification of Circularly Polarized Luminescence in Chiral Metal Cluster Ensembles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jia-Yin WangState Key Laboratory of Fine Chemicals, Zhang Dayu College of Chemistry, Dalian University of Technology, Dalian, 116024, China.
Yubing SiCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Xi-Ming LuoCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Zhao-Yang WangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Xi-Yan DongCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Peng LuoCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Chong ZhangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.
Chunying DuanState Key Laboratory of Fine Chemicals, Zhang Dayu College of Chemistry, Dalian University of Technology, Dalian, 116024, China.
Shuang-Quan ZangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.ORCID https://orcid.org/0000-0002-6728-0559
Zhengzhou University · CNDalian University of Technology · CN

Funding

National Natural Science Foundation of China 21825106National Natural Science Foundation of China 21975065National Natural Science Foundation of China 92061201National Natural Science Foundation of China U21A20277National Supercomputing Center in Zhengzhou
6 · The paper itself

Abstract

Chiral metal-organic frameworks (MOFs) are usually endowed by chiral linkers and/or guests. The strategy using chiral secondary building units in MOFs for solving the trade-off of circularly polarized luminescence (CPL)-active materials, high photoluminescence quantum yields (PLQYs) and high dissymmetry factors (|g

Indexed as

chirality transfercircularly polarized luminescencehierarchical assemblysilver clusters

Identifiers

PMID36840632
PMCPMC10161016
OpenAlexW4321851461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.